Home » Newsletters » BioWorld

BioWorld

March 4, 1996

View Archived Issues

IMMULOGIC'S ALLERVAX EFFECTIVE AGAINST RAGWEED

MATRIX REGISTERS TO SELL ANOTHER 2.5M SHARES FOR $50M

OTHER NEWS TO NOTE

RITONAVIR GETS FDA APPROVAL IN RECORD TIME

ANOTHER PROTEASE INHIBITOR GETS THUMBS UP FROM FDA PANEL

APPETITE-SUPPRESSING LEPTIN PROTEIN PLAYS INFERTILITY-FIGHTING PART TOO